Translate
Exozymes, Inc.
About
Exozymes, Inc. (NASDAQ:EXOZ) — investor relations, events, news, and company updates on 6ix.
Latest News
Mar 31 2026
eXoZymes Provides Fourth Quarter and Full Year 2025 Update
Mar 25 2026
eXoZymes to Host Fourth Quarter and Full Year 2025 Results Conference Call on Tuesday March 31, 2026
Mar 18 2026
Successful Pilot Scale Run with Cayman Chemical Validates eXoZymes' Technology and Scalability
Mar 12 2026
eXoZymes' CCO Damien Perriman to Present a NCT Solution at Next Week's MISTA Symposium
Feb 10 2026
With Refreshed Brand eXoZymes Sharpens Pharmaceutical Focus to Drive Platform Leverage and Long-Term Value Creation
Financials
Revenue
-$700
Market Cap
$85.21 M
EPS
-1.09